TY  - JOUR
PY  - 2006//
TI  - The cost-effectiveness of cognitive behavior therapy for borderline personality disorder: results from the BOSCOT trial
JO  - Journal of personality disorders
A1  - Palmer, Stephen
A1  - Davidson, Kate
A1  - Tyrer, Peter
A1  - Gumley, Andrew
A1  - Tata, Philip
A1  - Norrie, John
A1  - Murray, Heather
A1  - Seivewright, Helen
SP  - 466
EP  - 481
VL  - 20
IS  - 5
N2  - Borderline personality disorder places a significant burden on healthcare providers and other agencies. This study evaluated the cost-effectiveness of cognitive behavior therapy plus treatment as usual compared to treatment as usual alone for patients with borderline personality disorder. The economic analysis was conducted alongside a multi-center, randomized controlled trial. The costs of primary and secondary healthcare utilization, alongside the wider economic costs, were estimated from medical records and patient self-report. The primary outcome measure used was the quality-adjusted life year (QALY), assessed using EuroQol. On average, total costs per patient in the cognitive behavior therapy group were lower than patients receiving usual care alone (-689 pounds sterling), although this group also reported a lower quality of life (-0.11 QALYs). These differences were small and did not approach conventional levels of statistical significance. The use of cognitive therapy for borderline personality disorder does not appear to demonstrate any significant cost-effective advantage based on the results of this study.<p /> <p>Language: en</p>
LA  - en
SN  - 0885-579X
UR  - http://dx.doi.org/10.1521/pedi.2006.20.5.466
ID  - ref1
ER  -